The global surgical sutures market size was valued at USD 3.5 billion in 2017 and is expected to expand at a CAGR of 6.5% over the forecast period. Increase in the number of surgeries due to unhealthy lifestyle and aging population are anticipated drive the market.
Improved safety and efficacy of various surgeries due to technological advancements is also expected to boost the market demand. Initiatives, such as acquisitions and partnerships, undertaken by key companies for product development and distribution activities are expected propel the market further during the forecast years.
Flexible government regulations for surgical procedures, aging baby boomers, and the introduction of technologically advanced products are likely to increase number of surgeries and thereby the market in the coming years. For instance, every year in U.S., surgeons perform about 64 million surgeries ranging from tooth extraction to open-heart procedure.
Increase in awareness about surgeries in the developing region, investment by market players in emerging markets, and developing imaging and diagnosis techniques are the other key factors to boost the growth in coming years.
Based on type, the market has been segmented into absorbable and nonabsorbable sutures. In 2017, absorbable suture accounted for the largest share of the market and is expected to maintain its position during the forecast period. This can be attributed to the ability of the suture to provide temporary support to wound until it heals significantly. Furthermore, it is cost effective as it dissolves in the body after a certain period.
Nonabsorbable sutures are majorly used on skin wound closure where stitches can be removed after few weeks or in a stressful internal environment where absorbable sutures are unable to fulfill the requirement. Special silk, stainless steel wires, synthetics polypropylene, polyester, and nylon are the major material used for nonabsorbable sutures.
Based on the type of filament, the sutures market has been segmented into monofilament and multifilament sutures. Multifilament accounted for the maximum market share in 2017 due to its greater strength, more flexibility, and pliability. Increased number of complicated surgeries, availability of more products, and high cost over monovalent sutures are likely to drive the segment in the coming years.
Based on application, the surgical sutures market is divided into ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, and others. Cardiovascular surgery accounted for the largest market share in 2017 and is expected to expand at the fastest CAGR during the forecast period. This can be attributed to the increasing incidence rate of cardiovascular diseases and technological advancements in diagnostics, imaging, and surgical tools.
The others segment includes gynecology and obstetrics surgery, urology, gastrointestinal surgery, general surgery, and oral surgery. The increasing number of obese population and rise in the number of women’s health issues are likely to drive this segment significantly over the forecast period.
North America held the highest market share of more than 40.0% market share in 2017. This is due to the factors, such as adoption of technologically advanced devices, high domestic income, and local presence of major companies. For instance, Ethicon and Medtronic have a strong presence in this region.
Asia Pacific is expected to grow at a rapid pace over the forecast period owing to the introduction of technologically advanced products due to investment by market players in this region, high volume of surgeries, and growing consumer disposable income levels. China, Japan, and India are the major markets in the Asia Pacific region. Increasing medical tourism is another key factor for the rise in the number of surgical procedures and thereby sutures market in the region.
Some of the major companies operating in the global market are Medtronic, Ethicon, Smith & Nephew, Sutures India Pvt. Ltd., Internacional Farmacéutica., Péters Surgical, and Integra LifeSciences. M & A and collaborations are the key market strategies undertaken by the companies to strengthen their global presence.
For instance, in February 2017, Integra LifeSciences acquired Derma Sciences. This acquisition facilitated Integra LifeSciences to expand their product portfolio and double the number of wound care sales channels.
Report Attribute |
Details |
Market size value in 2020 |
USD 4,300.4 million |
Revenue forecast in 2025 |
USD 5,910.2 million |
Growth Rate |
CAGR of 6.5% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Type, filament, application, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; Spain; Italy; France; U.K.; Japan; China; Brazil; Mexico; South Africa |
Key companies profiled |
Medtronic; Ethicon; Smith & Nephew; Sutures India Pvt. Ltd.; Internacional Farmacéutica.; Péters Surgical; Integra LifeSciences |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global surgical sutures market report on the basis of type, filament, application, and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Absorbable
Nonabsorbable
Filament Outlook (Revenue, USD Million, 2014 - 2025)
Monovalent
Multivalent
Application Outlook (Revenue, USD Million, 2014 - 2025)
Ophthalmic Surgery
Cardiovascular Surgery
Orthopedic Surgery
Neurological Surgery
Others
End Use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Ambulatory Surgical Centers and Clinics
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
Spain
Italy
France
U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
b. The global surgical sutures market size was estimated at USD 4,048.4 million in 2019 and is expected to reach USD 4,300.4 million in 2020.
b. The global surgical sutures market is expected to grow at a compound annual growth rate of 6.5% from 2019 to 2025 to reach USD 5,910.2 million by 2025.
b. North America dominated the surgical sutures market with a share of 41.0% in 2019. This is attributable to the adoption of technologically advanced devices, high domestic income, and local presence of major companies.
b. Some key players operating in the surgical sutures market include Medtronic, Ethicon, Smith & Nephew, Sutures India Pvt. Ltd., Internacional Farmacéutica., Péters Surgical, and Integra LifeSciences.
b. Key factors that are driving the market growth include increase in the number of surgeries due to unhealthy lifestyle and aging population, and initiatives, such as acquisitions and partnerships, undertaken by key companies for product development and distribution activities.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.